Ishizuya Yu

Research field (1)： Urology

Research keywords (1)： Urology

Research theme for competitive and other funds (3)：

2021 - 2024 DNA損傷応答に着目した機能喪失スクリーニングによる前立腺癌の新規治療法の開発
2019 - 2021 Identification of synthetic lethal genes with PARP in prostate cancer
2017 - 2019 Identification of renal cancer-specific mutations in circulating tumor DNA and its clinical application to liquid biopsy

Papers (108)：

Akinaru Yamamoto, Atsunari Kawashima, Shinsuke Sakai, Masashi Mita, Nesrine Sassi, Shunsuke Inoguchi, Yuki Horibe, Akihiro Yoshimura, Masaru Tani, Liu Yutong, et al. Serum D-asparagine concentration adjusted for eGFR could serve as a novel screening tool for urothelial carcinoma. Biochemical and biophysical research communications. 2024. 733. 150701-150701
Akihiro Yoshimura, Taigo Kato, Yasutomo Nakai, Masao Tsujihata, Shingo Toyoda, Mototaka Sato, Kyosuke Matsuzaki, Wataru Nakata, Tetsuya Takao, Syunsuke Inoguchi, et al. Clinical outcomes of first-line combination therapy with immune checkpoint inhibitor for metastatic non-clear cell renal cell carcinoma: a multi-institutional retrospective study in Japan. International journal of clinical oncology. 2024
山道岳, 加藤大悟, 荒川憲昭, 氏家剛, 本山雄一, 王谷英達, 明庭昇平, 石津谷祐, 山本致之, 波多野浩士, et al. GDPPはvicious cycleを亢進させて骨転移を有する去勢抵抗性前立腺癌における血中骨転移バイオマーカーとなる. 泌尿器外科. 2024. 37. 8. 892-893
Atsunari Kawashima, Yu Ishizuya, Yoshiyuki Yamamoto, Taigo Kato, Koji Hatano, Norio Nonomura. Recent developments and future directions of first-line systemic therapy combined with immunotherapy for advanced or metastatic urothelial carcinoma: a historical perspective on treatment evolution. International journal of clinical oncology. 2024. 29. 8. 1096-1104
植村俊彦, 河嶋厚成, 神宮司健太郎, 元岡大祐, ネスリン・サッシ, 岡利樹, 奥田洋平, 山本顕生, 山道岳, 冨山栄輔, et al. 血中細胞外小胞内の細菌由来DNAは腎癌診断および免疫治療予後予測マーカーとなる. 腎癌研究会会報. 2024. 54. 116-116

ｍore...

MISC (77)：

サシネスリン, 河嶋厚成, 山本顕生, 木村友則, 三田真史, 山本致之, 石津谷祐, 加藤大悟, 波多野浩士, 野々村祝夫. D-Amino acids, promotes Urothelial cancer cell proliferation, invasion and migration. 泌尿器科分子・細胞研究会プログラム・抄録集. 2024. 33rd
河嶋厚成, 山本顕生, ネスリンサッシ, 木村友則, 三田真史, 神宮司健太郎, 植村俊彦, 山道岳, 冨山栄輔, 石津谷祐, et al. Diagnostic and prognostic markers using bacterial genetic and metabolize information within urogenital cancer patients. 日本癌学会学術総会抄録集(Web). 2023. 82nd. 1577-1577
河嶋厚成, 山本顕生, NESRINE Sassi, 木村友則, 三田真史, 植村俊彦, 山道岳, 冨山栄輔, 石津谷祐, 山本致之, et al. Development of blood based diagnostic markers of urothelial carcinoma using chiral amino acids. 日本泌尿器科学会総会(Web). 2023. 110th
加藤大悟, 森下康一, 冨山栄輔, 植村俊彦, 山本顕生, 奥田洋平, 藤田和利, 石津谷祐, 山本致之, 波多野浩士, et al. Fucosylated haptoglobin as a predictive biomarker following immune checkpoint inhibitors in advanced renal cell carcinoma. 日本泌尿器科学会総会(Web). 2023. 110th
波多野浩士, 岡利樹, 二村圭祐, 石津谷祐, 奥田洋平, 植村俊彦, 山道岳, 冨山栄輔, 山本致之, 加藤大悟, et al. Systematic mapping of radiosensitivity and gene interactions identifies a novel therapeutic target in prostate cancer. 日本泌尿器科学会総会(Web). 2023. 110th

ｍore...

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page